Kiora Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPRX and other ETFs, options, and stocks.About KPRX
Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102.
KPRX Key Statistics
Stock Snapshot
The current Kiora Pharmaceuticals(KPRX) stock price is $2.45, with a market capitalization of 9.92M. The stock trades at a price-to-earnings (P/E) ratio of -0.88.
On 2026-05-10, Kiora Pharmaceuticals(KPRX) stock traded between a low of $2.40 and a high of $2.71. Shares are currently priced at $2.45, which is +2.1% above the low and -9.6% below the high.
The Kiora Pharmaceuticals(KPRX)'s current trading volume is 40.75K, compared to an average daily volume of 74.03K.
In the last year, Kiora Pharmaceuticals(KPRX) shares hit a 52-week high of $4.18 and a 52-week low of $1.76.
In the last year, Kiora Pharmaceuticals(KPRX) shares hit a 52-week high of $4.18 and a 52-week low of $1.76.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.